InfuSystem Holdings (INFU) Research & Development (2010 - 2026)

InfuSystem Holdings (INFU) posted Research & Development of $3.1 million for Q1 2026, up 26.64% on a QoQ basis from $2.4 million in Q4 2025, and up 3.18% year-over-year from $3.0 million in Q1 2025.

InfuSystem Holdings (INFU) Research & Development (2010 - 2026) Analysis & Trends

InfuSystem Holdings' Research & Development history runs 17 years deep, the most recent figure standing at $3.1 million for Q1 2026.

  • Quarterly Research & Development rose 3.18% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.6 million (down 3.1% YoY) and the FY2025 annual result came in at $10.5 million, down 7.29% from the prior year.
  • Research & Development was $3.1 million for Q1 2026 at InfuSystem Holdings, up from $2.4 million in the prior quarter.
  • Across five years, Research & Development topped out at $3.7 million in Q4 2023 and bottomed at $2.1 million in Q4 2024.
  • A 5-year average of $2.9 million and a median of $3.0 million in 2023 frame the typical range for Research & Development.
  • Annual changes were most pronounced in 2022 — Research & Development jumped 39.69% — and 2024, when it plunged 42.45%.
  • InfuSystem Holdings' Research & Development stood at $3.0 million in 2022, then advanced by 25.45% to $3.7 million in 2023, then plunged by 42.45% to $2.1 million in 2024, then advanced by 13.7% to $2.4 million in 2025, then climbed by 26.64% to $3.1 million in 2026.
  • Business Quant data shows INFU's Research & Development at $3.1 million in Q1 2026, $2.4 million in Q4 2025, and $2.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 767.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 413.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 671.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 516.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 263.30 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 145.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -461.27 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 345.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 InfuSystem Holdings 179.47 Mn 177.37 Mn 19.68 Mn 3.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.08 Mn
Dec 31, 2025 2.43 Mn
Sep 30, 2025 2.37 Mn
Jun 30, 2025 2.70 Mn
Mar 31, 2025 2.99 Mn
Dec 31, 2024 2.14 Mn
Sep 30, 2024 2.76 Mn
Jun 30, 2024 3.04 Mn
Mar 31, 2024 3.38 Mn
Dec 31, 2023 3.72 Mn
Sep 30, 2023 2.73 Mn
Jun 30, 2023 2.99 Mn
Mar 31, 2023 3.22 Mn
Dec 31, 2022 2.96 Mn
Sep 30, 2022 2.89 Mn
Jun 30, 2022 3.08 Mn
Mar 31, 2022 3.32 Mn
Dec 31, 2021 2.81 Mn
Sep 30, 2021 2.91 Mn
Jun 30, 2021 2.68 Mn